Trial Profile

Phase I COVID-19 vaccine study for treatment of corona virus infection

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 20 May 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MT 2766 (Primary)
Indications Coronavirus infections; COVID 2019 infections
Focus Adverse reactions
Sponsors Medicago

Most Recent Events

14 May 2020 According to a Medicago media release, the company will submit an investigational new drug submission with the FDA in the United States to allow for the initiation of human clinical trials this summer.
18 Mar 2020 New trial record
12 Mar 2020 According to a Medicago media release, the company expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com